Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)
The shareholders in Moberg Pharma AB (publ) (reg. no. 556697-7426) (the “Company” or “Moberg Pharma”) are hereby convened to the Extraordinary General Meeting on Tuesday, 28 April 2020 at 4:30 p.m. (CET) in the Company’s premises in Bromma, address Gustavslundsvägen 42, 5 tr, 167 51 Bromma (Alviks torg), Sweden.Attendance at the Extraordinary General Meeting Shareholders who wish to participate in the Extraordinary General Meeting must: · be recorded in the share register maintained by Euroclear Sweden AB (“Euroclear”), on Wednesday, 22 April 2020, and · give notice of attendance